Thermo Fisher Scientific Inc. provided earnings guidance for the full year 2018. Free cash flow is expected to be approximately $3.8 billion in 2018. The increase over 2017 is mainly due to higher earnings. The company is assuming an adjusted income tax rate of 12%, this compares to 13% for 2017. In terms of its revenue, the company expects to deliver from $23.42 billion to $23.72 billion in 2018, which would result in 12% to 13% growth over 2017. The company is initiating adjusted EPS guidance for 2018 in the range of $10.68 to $10.88 per share. The company expects net interest expense to be in the range of $550 million to $555 million, about $40 million higher than 2017, primarily as a result of the debt it took on for acquisitions in 2017 and assumed rate increases in 2018. The company is assuming net capital expenditures to be approximately $700 million to $730 million for the year. The increase over 2017 is due to the timing of projects and the full year impact of Patheon.